课题基金 / 基金详情

Coordinating targeted delivery of latency-reversing drugs and enhanced antiviral T-cell responses to eradicate HIV infection

Coordinating targeted delivery of latency-reversing drugs and enhanced antiviral T-cell responses to eradicate HIV infection
协调潜伏期逆转药物的靶向递送和增强抗病毒 T 细胞反应以根除 HIV 感染
批准号:
275650
负责人:
Jones Brad R
金额:
$10.2万
依托单位国家:
加拿大
项目类别:
Fellowship Programs
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-11-01 至 2014-11-01

项目摘要

项目成果

Jones Brad R的其他基金

相关文献

中文摘要
翻译
虽然目前的药物可以极大地改善艾滋病毒/艾滋病患者的生活,但它们不能治愈感染。治疗是一项昂贵的终身承诺,并伴有严重降低生活质量的副作用。有
英文摘要
Although current medications can dramatically improve the lives of people living with HIV/AIDS they cannot cure infection. Treatment is an expensive lifelong commitment, and is associated with side-effects which substantially reduce quality of life. There
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
64th Lindau Nobel Laureate Meeting Recipient